(Q38184377)

30 August 2017

title

Tissue prognostic biomarkers in primary cutaneous melanoma (English)

1 reference

30 August 2017

0 references

Mario Mandalà

1

1 reference

30 August 2017

Daniela Massi

series ordinal

2

1 reference

30 August 2017

publication date

1 February 2014

1 reference

30 August 2017

1 reference

30 August 2017

volume

464

1 reference

30 August 2017

issue

3

1 reference

30 August 2017

page(s)

265-281

1 reference

Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

21 January 2018

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Final version of 2009 AJCC melanoma staging and classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

REporting recommendations for tumour MARKer prognostic studies (REMARK)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Publication of tumor marker research results: the necessity for complete and transparent reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Melanoma prognosis: a REMARK-based systematic review and bioinformatic analysis of immunohistochemical and gene microarray studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Predicting survival outcome of localized melanoma: an electronic prediction tool based on the AJCC Melanoma Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Prognostic models for subgroups of melanoma patients from the Scottish Melanoma Group database 1979-86, and their subsequent validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

A prognostic model for predicting 10-year survival in patients with primary melanoma. The Pigmented Lesion Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

A landscape of driver mutations in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Mitotic rate in melanoma should be recorded as the number of mitoses per mm² (not per high power field): surgeons tell your pathologists!

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Prognostic importance of the extent of ulceration in patients with clinically localized cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Surveillance against tumors--is it mainly immunological?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

A prognostic model for clinical stage I melanoma of the trunk. Location near the midline is not an independent risk factor for recurrent disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Model predicting survival in stage I melanoma based on tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Thin malignant melanomas (less than 1.5 mm) with metastasis: a histological study and survival analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Objective assessment of blood and lymphatic vessel invasion and association with macrophage infiltration in cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Tumour lymphangiogenesis is a possible predictor of sentinel lymph node status in cutaneous melanoma: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Lymphatic invasion is independently prognostic of metastasis in primary cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Lymphatic invasion revealed by multispectral imaging is common in primary melanomas and associates with prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Selective immunohistochemical staining shows significant prognostic influence of lymphatic and blood vessels in patients with malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

High lymphatic vessel density and lymphatic invasion underlie the adverse prognostic effect of radial growth phase regression in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Clinical relevance of detection of lymphovascular invasion in primary melanoma using endothelial markers D2-40 and CD34

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Immunohistochemical detection of lymphovascular invasion with D2-40 in melanoma correlates with sentinel lymph node status, metastasis and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

The development of optimal pathological assessment of sentinel lymph nodes for melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

EORTC Melanoma Group sentinel node protocol identifies high rate of submicrometastases according to Rotterdam Criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Prognosis in patients with sentinel node-positive melanoma is accurately defined by the combined Rotterdam tumor load and Dewar topography criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Prognostic evaluation of cutaneous malignant melanoma: a clinicopathologic and immunohistochemical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Prognostic significance of nuclear receptor coactivator-3 overexpression in primary cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Strong expression of ID1 protein is associated with decreased survival, increased expression of ephrin-A1/EPHA2, and reduced thrombospondin-1 in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Novel role for RGS1 in melanoma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

HER3 is a determinant for poor prognosis in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Prognostic importance of the mitotic marker phosphohistone H3 in cutaneous nodular melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Cytoplasmic Skp2 expression is increased in human melanoma and correlated with patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Automated quantitative analysis of activator protein-2alpha subcellular expression in melanoma tissue microarrays correlates with survival prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Differential expression of DNA nonhomologous end-joining proteins Ku70 and Ku80 in melanoma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Microtubule-associated protein 2, a marker of neuronal differentiation, induces mitotic defects, inhibits growth of melanoma cells, and predicts metastatic potential of cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Role of ING4 in human melanoma cell migration, invasion and patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Loss of SNF5 expression correlates with poor patient survival in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: an analysis of 215 cases from the Malmö Diet and Cancer Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Prognostic significance of Sox4 expression in human cutaneous melanoma and its role in cell migration and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Automated quantitative analysis of tissue microarrays reveals an association between high Bcl-2 expression and improved outcome in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Expression of glucose-regulated stress protein GRP78 is related to progression of melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Molecular classification of cutaneous malignant melanoma by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Melanoma molecular classes and prognosis in the postgenomic era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

A gene expression signature associated with survival in metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Gene Expression Profiling of Primary Cutaneous Melanoma and Clinical Outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Increased expression of the tumor suppressor PLZF is a continuous predictor of long-term survival in malignant melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Predicting clinical outcome through molecular profiling in stage III melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Gene expression profiling of paraffin-embedded primary melanoma using the DASL assay identifies increased osteopontin expression as predictive of reduced relapse-free survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

The gene expression signatures of melanoma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

MicroRNA expression profiles associated with mutational status and survival in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Melanoma MicroRNA signature predicts post-recurrence survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Identification of new genes associated with melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

High tPA-expression in primary melanoma of the limb correlates with good prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Reduced level of CD44 and hyaluronan associated with unfavorable prognosis in clinical stage I cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Development of a tissue array for primary melanoma with long-term follow-up: discovering melanoma cell adhesion molecule as an important prognostic marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Stratification of patients by melanoma cell adhesion molecule (MCAM) expression on the basis of risk: implications for sentinel lymph node biopsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Metallothionein - overexpression as a highly significant prognostic factor in melanoma: a prospective study on 1270 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Tumor necrosis is associated with increased alphavbeta3 integrin expression and poor prognosis in nodular cutaneous melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

The role of RhoC in growth and metastatic capacity of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Prognostic significance of cadherin-based adhesion molecules in cutaneous malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Loss of BMI-1 expression is associated with clinical progress of malignant melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Lactate dehydrogenase 5 expression in melanoma increases with disease progression and is associated with expression of Bcl-XL and Mcl-1, but not Bcl-2 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

A multimarker prognostic assay for primary cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Melanoma prognostic model using tissue microarrays and genetic algorithms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Mutational heterogeneity in cancer and the search for new cancer-associated genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Mutation-driven drug development in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Mutations of the BRAF gene in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

The prognostic value of BRAF mutation in colorectal cancer and melanoma: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Clinical Correlates of NRAS and BRAF Mutations in Primary Human Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Prevalence of BRAF V600E mutation in Chinese melanoma patients: large scale analysis of BRAF and NRAS mutations in a 432-case cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Clinical outcome and pathological features associated with NRAS mutation in cutaneous melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

BRAF mutation, NRAS mutation, and the absence of an immune-related expressed gene profile predict poor outcome in patients with stage III melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I–II AJCC skin melanoma: Outcome analysis from a single-institution prospectively collected database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

nm23 as a prognostic marker in primary cutaneous melanoma: evaluation using tissue microarray in a patient group with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

CD44v3 levels in primary cutaneous melanoma are predictive of prognosis: Assessment by the use of tissue microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

A High-Throughput Study in Melanoma Identifies Epithelial-Mesenchymal Transition as a Major Determinant of Metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Systematic search for the best gene expression markers for melanoma micrometastasis detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1526-X

Combinations of apoptosis and cell-cycle control biomarkers predict the outcome of human melanoma

21 January 2018

1 reference

12 December 2020

Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate

1 reference

12 December 2020

Loss of nuclear p16 protein expression correlates with increased tumor cell proliferation (Ki-67) and poor prognosis in patients with vertical growth phase melanoma

1 reference

12 December 2020

Immunohistochemical expression of nm23 in primary invasive malignant melanoma is predictive of survival outcome

1 reference

12 December 2020

Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma

1 reference

12 December 2020

High expression of DNA repair pathways is associated with metastasis in melanoma patients

1 reference

12 December 2020

Downregulation of transcription factor AP-2 predicts poor survival in stage I cutaneous malignant melanoma

1 reference

12 December 2020

Skp2 and p27kip1 expression in melanocytic nevi and melanoma: an inverse relationship

1 reference

12 December 2020

Comparison of metallothionein-overexpression with sentinel lymph node biopsy as prognostic factors in melanoma

1 reference

12 December 2020

Predicting five-year outcome for patients with cutaneous melanoma in a population-based study

1 reference

12 December 2020

Overexpression of the cell adhesion molecule L1 is associated with metastasis in cutaneous malignant melanoma

1 reference

12 December 2020

Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma

1 reference

12 December 2020

Subcellular localization of activating transcription factor 2 in melanoma specimens predicts patient survival.

1 reference

12 December 2020

Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma

1 reference

12 December 2020

E- to N-cadherin switch in melanoma is associated with decreased expression of phosphatase and tensin homolog and cancer progression

1 reference

12 December 2020

Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome

1 reference

12 December 2020

Thin primary cutaneous malignant melanoma: a prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer staging

1 reference

12 December 2020

A novel and accurate computer model of melanoma prognosis for patients staged by sentinel lymph node biopsy: comparison with the American Joint Committee on Cancer model

1 reference

12 December 2020

Technical details of intraoperative lymphatic mapping for early stage melanoma

1 reference

12 December 2020

Prognostic value of galectin-3 in primary cutaneous melanoma

1 reference

12 December 2020

Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single center

1 reference

12 December 2020

High frequency of melanoma-associated antigen or HLA class I loss does not correlate with survival in primary melanoma

1 reference

12 December 2020

Clinicopathologic and prognostic significance of SATB1 in cutaneous malignant melanoma

1 reference

12 December 2020

Automated quantitative analysis of HDM2 expression in malignant melanoma shows association with early-stage disease and improved outcome

1 reference

12 December 2020

Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma

1 reference

12 December 2020

Levels of cyclin D1 and D3 in malignant melanoma: deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma

1 reference

12 December 2020

Lymphatic invasion in cutaneous melanoma is associated with sentinel lymph node metastasis

1 reference

12 December 2020

Histological characteristics of metastasizing thin melanomas: a case-control study of 43 cases

1 reference

12 December 2020

Malignant melanoma; a clinicopathological analysis of the criteria for diagnosis and prognosis

1 reference

12 December 2020

CEACAM1 expression in cutaneous malignant melanoma predicts the development of metastatic disease

1 reference

12 December 2020

Predicting ten-year survival of patients with primary cutaneous melanoma: corroboration of a prognostic model

1 reference

12 December 2020

The histogenesis and biologic behavior of primary human malignant melanomas of the skin

1 reference

12 December 2020

Osteopontin as a molecular prognostic marker for melanoma

1 reference

12 December 2020

Identification of P-cadherin in primary melanoma using a tissue microarrayer: prognostic implications in a patient cohort with long-term follow up

1 reference

12 December 2020

Nuclear survivin is associated with disease recurrence and poor survival in patients with cutaneous malignant melanoma

1 reference

12 December 2020

Tumor iNOS predicts poor survival for stage III melanoma patients

1 reference

12 December 2020

Primary cutaneous melanoma with regression does not require a lower threshold for sentinel lymph node biopsy

1 reference

12 December 2020

Tenascin-C in primary malignant melanoma of the skin

1 reference

12 December 2020

Expression of CXCR4 Predicts Poor Prognosis in Patients with Malignant Melanoma

1 reference

12 December 2020

Identification of high-risk patients among those diagnosed with thin cutaneous melanomas

1 reference

12 December 2020

10.1007/S00428-013-1526-X

Identifiers

DOI

1 reference

30 August 2017

1 reference